Variable Value
Age median (range), y 12 (5-21)
Sex n (%)
Male 12 (41)
Female 17 (59)
Genotype n (%)
HgbSS 29 (100)
Clinical treatment plan n (%)
Hydroxyurea 2 (7)
Chronic transfusion therapy 19 (66)
Previous Bone Marrow Transplant 1 (3)
Previous Bone Marrow Transplant + chronic transfusions 5 (17)
EDAS* + chronic transfusions 2 (7)
Degree of objective neurologic disease n (%)
None 8 (27)
TIA (clinically) 2 (7)
Silent infarct 18 (62)
Symptomatic stroke 11 (38)